GS
Glenn Sussman
Co-founder & Chief Technology AdvisorMr. Glenn Sussman serves as Vice President of R&D at ClarVista Medical, Inc. Mr. Sussman has 24 years in ophthalmic device development with Alcon and Allergan. He is a Prolific Inventor with 37 patents and is a Seasoned technical leader. He served as CEO and Director at SpyGlass Ophthalmics, Inc. He co-founded SpyGlass in January 2019 and Chief Technology Advisor since January 2026 at SpyGlassPharma, Inc. He served as Chief Executive Officer through July 2021 at SpyGlass Pharma, Inc. He transitioned to SpyGlass Pharma, Inc. Chief Technology Officer in July 2021 and continued to serve in that role through December 2025. Mr. Sussman holds a B.S. in mechanical engineering from California State University, Long Beach.
Positions
- Company NameSpyGlass Pharma, Inc.Stock CodeSGPPositionCo-founder & Chief Technology AdvisorColleagues
- MYMalik Y. KahookCo-Founder, President, Chief Medical Officer & Executive Chairman
- PHPatrick H. MooneyCEO & Director
- CPChetan PujaraChief Research & Development Officer
- JVJean-Frederic ViretChief Financial Officer
- ZSZachary ScheinerIndependent Director
- BABilal Arshad KhanIndependent Director
- EGElizabeth G. O’FarrellIndependent Director
